FRONTEO's drug discovery support AI technology was introduced on page 2 of the Nikkei Sangyo Shimbun dated 9/1 and in the Nikkei electronic version.

"The next-generation" main drug "is AI," in silico drug discovery "that exceeds human knowledge, and half the time and cost (STARTupX)."

 

Click here for FRONTEO's AI drug discovery.
https://lifescience.fronteo.com/aidiscovery/